APA (7th ed.) Citation

Li, X., Guo, W., Chen, J., & Tan, G. (2024). The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions. Clinical pharmacology in drug development, 13(9), 1061-1070. https://doi.org/10.1002/cpdd.1448

Chicago Style (17th ed.) Citation

Li, Xiang, Wenqiang Guo, Jian Chen, and Gewen Tan. "The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions." Clinical Pharmacology in Drug Development 13, no. 9 (2024): 1061-1070. https://doi.org/10.1002/cpdd.1448.

MLA (9th ed.) Citation

Li, Xiang, et al. "The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions." Clinical Pharmacology in Drug Development, vol. 13, no. 9, 2024, pp. 1061-1070, https://doi.org/10.1002/cpdd.1448.